Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 275 No 7359 p108
23 July 2005

This article
Reprint   Photocopy

  Acrobat Reader


News summary


Buccal route is an alternative for treating acute seizures in children

Buccal midazolam is more effective than rectal diazepam for treating acute seizures in children, a UK study has shown (Lancet 2005;366:205).

The trial, based at Alder Hey Children’s Hospital, Liverpool, Derbyshire Children’s Hospital, Birmingham Children’s Hospital and Queen’s Medical Centre, Nottingham, compared the treatments across 219 episodes in 177 children aged over six months who presented to hospital with seizures and could not be treated with intravenous drugs.

The therapeutic success rate, defined as cessation of seizure within 10 minutes of drug administration without either respiratory depression or another seizure within an hour, was 56 per cent (61 of 109) for buccal midazolam and 27 per cent (30 of 110) for rectal diazepam.

The authors explain that intravenous access is not always possible in children having a seizure and that an effective and safe alternative is frequently required. “Despite some initial reservations, anecdotal comments from staff in [accident and emergency departments] suggest that the buccal route was easy to use,” they add.

Use of the buccal route by non-trained carers in non-hospital situations will, they say, be the topic for future work.

Back to Top


©The Pharmaceutical Journal